These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6174232)

  • 1. Combination chemotherapy for the 9L rat brain tumor model system.
    Vats TS; Kimler BF; Henderson SD; Morantz RA
    Cancer Treat Rep; 1982 Mar; 66(3):575-9. PubMed ID: 6174232
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
    Kokunai T; Kuwamura K
    No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of perfluorochemicals on BCNU chemotherapy in a 9L rat brain tumor model].
    Kokunai T; Kuwamura K
    Neurol Med Chir (Tokyo); 1982 Oct; 22(10):777-83. PubMed ID: 6185861
    [No Abstract]   [Full Text] [Related]  

  • 4. Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.
    Corbett TH; Griswold DP; Wolpert MK; Venditti JM; Schabel FM
    Cancer Treat Rep; 1979 May; 63(5):799-801. PubMed ID: 455319
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain tumor chemotherapy: translation of laboratory experiments into clinical trials.
    Wilson CB; Wheeler K; Levin VA; Rosenblum M; Barker M
    Trans Am Neurol Assoc; 1976; 101():214-6. PubMed ID: 1028238
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibility of the use of perfluorochemicals (fluorocarbons) as adjuvants in chemotherapy of cancer].
    Kuwamura K; Kokunai T
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1256-61. PubMed ID: 7184453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of experimental meningeal carcinomatosis (author's transl)].
    Shimizu K; Ushio Y; Hayakawa T; Ikeda H; Mogami H
    No To Shinkei; 1979 Mar; 31(3):323-30. PubMed ID: 87211
    [No Abstract]   [Full Text] [Related]  

  • 9. New delivery systems for brain tumor therapy.
    Sipos EP; Brem H
    Neurol Clin; 1995 Nov; 13(4):813-25. PubMed ID: 8583998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to the use of polyamine inhibitors for cancer therapy.
    Marton LJ
    Med Biol; 1981 Dec; 59(5-6):458-61. PubMed ID: 6803082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral chemotherapy in the 9L rat brain tumor model.
    Kimler BF; Liu C; Evans RG; Morantz RA
    J Neurooncol; 1992 Nov; 14(3):191-200. PubMed ID: 1281224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced effect of combined hyperthermia and chemotherapy (bleomycin, BCNU) in a neurogenic rat tumour (BT4A) in vivo.
    Dahl O; Mella O
    Anticancer Res; 1982; 2(6):359-64. PubMed ID: 6188410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carmustine and Baker's antifol combination chemotherapy for primary brain tumors progressive after irradiation and chemotherapy.
    Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD
    Cancer Treat Rep; 1984 Feb; 68(2):431-3. PubMed ID: 6697333
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor size, sensitivity to therapy, and design of treatment schedules.
    Norton L; Simon R
    Cancer Treat Rep; 1977 Oct; 61(7):1307-17. PubMed ID: 589597
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions of hyperthermia and chemotherapy in animals.
    Marmor JB
    Cancer Res; 1979 Jun; 39(6 Pt 2):2269-76. PubMed ID: 87264
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical concepts derived from animal chemotherapy studies.
    Goldin A; Schabel FM
    Cancer Treat Rep; 1981; 65 Suppl 3():11-9. PubMed ID: 7049366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
    Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Some methods of raising the selectivity of action of antineoplastic drugs].
    Sof'ina ZP; Lagova ND; Lesnaia NA; Babushkina NA
    Vestn Akad Med Nauk SSSR; 1984; (5):70-7. PubMed ID: 6741252
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations.
    Bodell WJ
    Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.